Takasu Junichiro, Uykimpang Rolando, Sunga Maria Alenor, Amagase Harunobu, Niihara Yutaka
Department of Medicine, Harbor-UCLA Medical Center, UCLA School of Medicine, Torrance, CA 90502, USA.
J Nutr. 2006 Mar;136(3 Suppl):803S-805S. doi: 10.1093/jn/136.3.803S.
Sickle-cell anemia is one of the most prevalent hereditary disorders with prominent morbidity and mortality. Oxidative phenomena play a significant role in the disorder's pathophysiology. A forumlation of garlic (Allium sativum), AGE, has been reported to exert an antioxidant effect in vitro. We evaluated the antioxidant effect of AGE on sickle red blood cells (RBCs). Five patients (two men and three women, mean age 40+/-15 years, range 24-58 years) with sickle-cell anemia participated in the study. AGE was administered at a dose of 5 mL daily. Whole blood samples were obtained at baseline and at 4 wk, primarily for Heinz body analysis. In all patients, the number of Heinz bodies decreased over the 4-wk period (58.9+/-20.0% at baseline to 29.8+/-15.3% at follow-up; P=0.03). These data suggest that AGE has a significant antioxidant activity on sickle RBCs. AGE may be further evaluated as a potential therapeutic agent to ameliorate complications of sickle-cell anemia.
镰状细胞贫血是最常见的遗传性疾病之一,具有显著的发病率和死亡率。氧化现象在该疾病的病理生理学中起重要作用。据报道,大蒜制剂(AGE)在体外具有抗氧化作用。我们评估了AGE对镰状红细胞(RBC)的抗氧化作用。五名镰状细胞贫血患者(两名男性和三名女性,平均年龄40±15岁,范围24 - 58岁)参与了该研究。AGE的给药剂量为每日5毫升。在基线和4周时采集全血样本,主要用于海因茨小体分析。在所有患者中,海因茨小体的数量在4周期间有所减少(基线时为58.9±20.0%,随访时为29.8±15.3%;P = 0.03)。这些数据表明AGE对镰状红细胞具有显著的抗氧化活性。AGE可作为一种潜在的治疗剂进一步评估,以改善镰状细胞贫血的并发症。